These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 17668858

  • 1. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S.
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [Abstract] [Full Text] [Related]

  • 2. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, Atlas MP, Gonzalez-Gomez I, Miller D, Finlay JL.
    Pediatr Blood Cancer; 2008 Mar; 50(3):715-7. PubMed ID: 17009232
    [Abstract] [Full Text] [Related]

  • 3. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
    Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J.
    Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
    [Abstract] [Full Text] [Related]

  • 4. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1031-7. PubMed ID: 16343801
    [Abstract] [Full Text] [Related]

  • 5. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.
    J Clin Oncol; 2004 Dec 15; 22(24):4881-7. PubMed ID: 15611503
    [Abstract] [Full Text] [Related]

  • 6. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H.
    Pediatr Blood Cancer; 2009 Jul 15; 52(7):796-803. PubMed ID: 19202566
    [Abstract] [Full Text] [Related]

  • 7. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J.
    Pediatr Blood Cancer; 2008 Aug 15; 51(2):235-40. PubMed ID: 18381756
    [Abstract] [Full Text] [Related]

  • 8. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.
    Pediatr Blood Cancer; 2007 Apr 15; 48(4):408-15. PubMed ID: 17066462
    [Abstract] [Full Text] [Related]

  • 9. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL.
    Cancer; 2009 Jul 01; 115(13):2956-63. PubMed ID: 19402050
    [Abstract] [Full Text] [Related]

  • 10. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 11. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
    Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL.
    Pediatr Blood Cancer; 2008 Jun 01; 50(6):1169-75. PubMed ID: 18293379
    [Abstract] [Full Text] [Related]

  • 12. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 13. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523
    [Abstract] [Full Text] [Related]

  • 14. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.
    Pediatr Blood Cancer; 2004 Jul 20; 43(1):46-54. PubMed ID: 15170889
    [Abstract] [Full Text] [Related]

  • 15. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
    Chintagumpala M, Hassall T, Palmer S, Ashley D, Wallace D, Kasow K, Merchant TE, Krasin MJ, Dauser R, Boop F, Krance R, Woo S, Cheuk R, Lau C, Gilbertson R, Gajjar A.
    Neuro Oncol; 2009 Feb 20; 11(1):33-40. PubMed ID: 18796696
    [Abstract] [Full Text] [Related]

  • 16. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

  • 17. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.
    Cancer J Sci Am; 1998 Sep 15; 4(2):110-24. PubMed ID: 9532413
    [Abstract] [Full Text] [Related]

  • 18. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
    McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1319-23. PubMed ID: 18485615
    [Abstract] [Full Text] [Related]

  • 19. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
    Pizer BL, Weston CL, Robinson KJ, Ellison DW, Ironside J, Saran F, Lashford LS, Tait D, Lucraft H, Walker DA, Bailey CC, Taylor RE.
    Eur J Cancer; 2006 May 01; 42(8):1120-8. PubMed ID: 16632346
    [Abstract] [Full Text] [Related]

  • 20. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.
    J Clin Oncol; 2001 May 15; 19(10):2696-704. PubMed ID: 11352962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.